The FDA was in the middle of a Pandemic where they
Post# of 148154
https://www.amarexcro.com/news/amarex-co-auth...ovid-paper
I would say that the FDA position as stated: "If CytoDyn plans further studies of leronlimab to determine whether the drug can provide clinical benefit to individuals with COVID-19, FDA will continue to provide advice to the company on their development program."